Anemia: A modifiable risk factor for heart disease

Reviews in Cardiovascular Medicine

Volumn 6, Issue SUPPL. 3, 2005, Pages

  McCullough, Peter A ^a   Lepor, Norman E ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; ERYTHROPOIETIN; HEMOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 6; IRON; MATRIX METALLOPROTEINASE; NEUROHORMONE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; DRUG HALF LIFE; EDITORIAL; ENDOTHELIUM CELL; EXERCISE TEST; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEMOGLOBIN DETERMINATION; HORMONE DEFICIENCY; HOSPITALIZATION; HUMAN; HYPERTENSION; IRON THERAPY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PREDICTION; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE; RISK FACTOR; RISK REDUCTION; SURVIVAL; THROMBOSIS; TREATMENT OUTCOME;

ANEMIA; HEART DISEASES; HUMANS; RISK FACTORS;

EID: 28644448254     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. NKF-DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. New York, National Kidney Foundation, 1997.
2. Pereira AA, Sarnak MJ. Anemia as a risk factor for cardiovascular disease. Kidney Int Suppl. 2003;(87):S32-S39.
3. McCullough PA, Lepor NE. The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and Treatment. Rev Cardiovasc Med. 2005;6(1):1-10.
4. Silverberg DS, Wexler D, Iaina A. The role of anemia in the progression of congestive heart failure. Is there a place for erythropietin and intravenous iron? J Nephrol. 2004;17(6):749-761.
5. Anand I, McMurray JJ, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004;110(2):149-154.
6. Mix TC, Brenner RM, Cooper ME, et al. Rationale - Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J. 2005;149:408-413.